Press releases
- Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.
- Dexcom Expands AID Partnership Into The Netherlands
- Dexcom Showcases Extensive Clinical Data at ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People With Type 2 Diabetes
- Dexcom G7 Now Connects Directly to Apple Watch in the U.S.
- Dexcom Wins Access to Dexcom ONE for 100,000 People Living With Type 2 Diabetes
- Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
- Dexcom Announces Upcoming Conference Presentation
- Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM
- Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes
- Dexcom Reports First Quarter 2024 Financial Results
More ▼
Key statistics
On Thursday, DEXCOM INC DRN (D1EX34:SAO) closed at 12.47, -13.70% below its 52-week high of 14.45, set on Apr 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 12.47 |
---|---|
High | 12.47 |
Low | 12.47 |
Bid | 11.50 |
Offer | 13.01 |
Previous close | 12.47 |
Average volume | 33.60 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jul 18 2024 10:44 BST.
More ▼